Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,125 | 155 | 99.7% |
| Education | $6.02 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $506.26 | 38 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $243.51 | 15 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $236.01 | 19 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $191.08 | 14 | $0 (2018) |
| GlaxoSmithKline, LLC. | $112.49 | 9 | $0 (2019) |
| Astellas Pharma US Inc | $107.91 | 6 | $0 (2019) |
| ABBVIE INC. | $90.54 | 7 | $0 (2024) |
| Eisai Inc. | $85.41 | 7 | $0 (2018) |
| PFIZER INC. | $78.43 | 6 | $0 (2019) |
| Lilly USA, LLC | $71.60 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $40.82 | 2 | Novo Nordisk Inc ($25.16) |
| 2019 | $503.74 | 36 | Novo Nordisk Inc ($97.04) |
| 2018 | $794.41 | 59 | Novo Nordisk Inc ($223.65) |
| 2017 | $791.79 | 59 | Novo Nordisk Inc ($160.41) |
All Payment Transactions
156 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: Diabetes | ||||||
| 07/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Diabetes | ||||||
| 09/30/2019 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $11.51 | General |
| 09/25/2019 | Novo Nordisk Inc | Tresiba (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Diabetes | ||||||
| 09/24/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: RESPIRATORY | ||||||
| 09/23/2019 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: DIABETES | ||||||
| 09/09/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/27/2019 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 08/26/2019 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $11.71 | General |
| Category: Obesity | ||||||
| 08/22/2019 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: NEUROLOGY | ||||||
| 08/07/2019 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Drug) | Food and Beverage | In-kind items and services | $13.71 | General |
| Category: DIABETES | ||||||
| 08/05/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Diabetes | ||||||
| 07/30/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: UROLOGY | ||||||
| 07/24/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: RESPIRATORY | ||||||
| 07/17/2019 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: DIABETES | ||||||
| 06/28/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: UROLOGY | ||||||
| 06/24/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/10/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: RESPIRATORY | ||||||
| 05/31/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: UROLOGY | ||||||
| 05/24/2019 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: DIABETES | ||||||
| 05/13/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: RESPIRATORY | ||||||
| 05/06/2019 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $13.12 | General |
| 05/01/2019 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/26/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 40 | 5,928 | 8,693 | $699,277 | $247,287 |
| 2022 | 37 | 5,428 | 7,762 | $598,216 | $206,905 |
| 2021 | 38 | 5,446 | 7,811 | $598,607 | $209,070 |
| 2020 | 41 | 5,013 | 6,670 | $498,590 | $160,987 |
All Medicare Procedures & Services
156 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 511 | 1,006 | $198,182 | $72,785 | 36.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 414 | 414 | $98,118 | $49,622 | 50.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 505 | 877 | $49,989 | $11,483 | 23.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 36 | 36 | $10,848 | $9,973 | 91.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 516 | 951 | $36,138 | $9,813 | 27.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 448 | 576 | $42,048 | $9,466 | 22.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 30 | 214 | $23,500 | $9,431 | 40.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 516 | 1,100 | $23,100 | $9,218 | 39.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 121 | 121 | $16,693 | $8,654 | 51.8% |
| 82306 | Vitamin d-3 level | Office | 2023 | 196 | 250 | $28,750 | $7,223 | 25.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 109 | 131 | $17,423 | $6,911 | 39.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 401 | 401 | $31,679 | $6,785 | 21.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 32 | 32 | $5,568 | $4,920 | 88.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 27 | 29 | $9,840 | $4,371 | 44.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 125 | 125 | $4,500 | $3,555 | 79.0% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 410 | 432 | $12,960 | $2,739 | 21.1% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 140 | 140 | $12,880 | $2,649 | 20.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 136 | 270 | $11,610 | $2,562 | 22.1% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 92 | 146 | $8,468 | $1,951 | 23.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 222 | 227 | $12,031 | $1,873 | 15.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 150 | 210 | $7,350 | $1,598 | 21.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 71 | 91 | $5,824 | $1,345 | 23.1% |
| 83550 | Iron binding capacity | Office | 2023 | 88 | 138 | $5,244 | $1,183 | 22.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 34 | 34 | $1,224 | $966.96 | 79.0% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 19 | 26 | $1,872 | $910.26 | 48.6% |
About Dr. Gregory Jenkins, MD
Dr. Gregory Jenkins, MD is a Internal Medicine healthcare provider based in Cordova, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225051246.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gregory Jenkins, MD has received a total of $2,131 in payments from pharmaceutical and medical device companies, with $40.82 received in 2024. These payments were reported across 156 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($2,125).
As a Medicare-enrolled provider, Jenkins has provided services to 21,815 Medicare beneficiaries, totaling 30,936 services with total Medicare billing of $824,250. Data is available for 4 years (2020–2023), covering 156 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Cordova, TN
- Active Since 07/25/2006
- Last Updated 10/24/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1225051246
Products in Payments
- Victoza (Drug) $228.71
- FARXIGA (Drug) $155.81
- XARELTO (Drug) $124.31
- MYRBETRIQ (Drug) $107.91
- TOUJEO (Drug) $99.64
- Tresiba (Drug) $96.23
- SOLIQUA (Drug) $87.57
- Ozempic (Drug) $86.88
- Belviq (Drug) $85.41
- TRELEGY ELLIPTA (Drug) $73.63
- INVOKANA (Drug) $66.77
- Androgel (Drug) $63.16
- CONTRAVE (Drug) $50.03
- JARDIANCE (Drug) $44.98
- SOLIQUA 100/33 (Drug) $42.89
- Vascepa (Drug) $38.63
- VYVANSE (Drug) $37.11
- BEVESPI AEROSPHERE (Drug) $35.08
- Trintellix (Drug) $28.13
- Tekturna (Drug) $27.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cordova
Mark Heckle, Md, MD
Internal Medicine — Payments: $31,714
Ms. Leigh Daigle, M.d, M.D
Internal Medicine — Payments: $1,508
Ahmad Al-Fakhouri, Md, MD
Internal Medicine — Payments: $812.36
Dr. Roger Gibson, M. D, M. D
Internal Medicine — Payments: $281.99
Dr. David Wright, M.d, M.D
Internal Medicine — Payments: $180.11
Dr. Catherine Womack, Md, MD
Internal Medicine — Payments: $28.64